Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

5.79
+0.16002.84%
Post-market: 5.790.00000.00%16:05 EDT
Volume:91.46K
Turnover:525.25K
Market Cap:123.52M
PE:-1.17
High:5.82
Open:5.63
Low:5.53
Close:5.63
Loading ...

Enanta Pharmaceuticals Fiscal Q4 Net Loss Widens, Revenue Declines

MT Newswires Live
·
26 Nov 2024

Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
26 Nov 2024

Enanta Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
26 Nov 2024

Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot

Associated Press Finance
·
26 Nov 2024

Enanta Pharma Q4 EPS $(1.36) Down From $(1.33) YoY, Sales $14.61M Down From $18.93M YoY

Benzinga
·
26 Nov 2024

Enanta Pharmaceuticals Sees Q4 2024 Revenue $14.6M Vs $17.9M Estimate; Sees Adj. EPS $-1.36 Vs $-1.16

Benzinga
·
26 Nov 2024

Enanta reports Q4 EPS ($1.36), consensus (92c)

TIPRANKS
·
26 Nov 2024

BRIEF-Enanta Pharmaceuticals Q4 Revenue USD 14.607 Million Vs. IBES Estimate USD 17.9 Million

Reuters
·
26 Nov 2024

Enanta Pharmaceuticals Q4 Pretax Profit USD -29.186 Million

THOMSON REUTERS
·
26 Nov 2024

Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Fourth Quarter and Year-Ended September 30, 2024

THOMSON REUTERS
·
26 Nov 2024

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024

Business Wire
·
26 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
25 Nov 2024

Enanta Pharmaceuticals Inc expected to post a loss of $1.16 a share - Earnings Preview

Reuters
·
23 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
21 Nov 2024

The past three years for Enanta Pharmaceuticals (NASDAQ:ENTA) investors has not been profitable

Simply Wall St.
·
27 Oct 2024